ATE546526T1 - Hybrid-interferenz-rna - Google Patents
Hybrid-interferenz-rnaInfo
- Publication number
- ATE546526T1 ATE546526T1 AT06743972T AT06743972T ATE546526T1 AT E546526 T1 ATE546526 T1 AT E546526T1 AT 06743972 T AT06743972 T AT 06743972T AT 06743972 T AT06743972 T AT 06743972T AT E546526 T1 ATE546526 T1 AT E546526T1
- Authority
- AT
- Austria
- Prior art keywords
- interference rna
- hybrid interference
- hybrid
- rna
- molecule
- Prior art date
Links
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 102000053602 DNA Human genes 0.000 abstract 1
- 108020004682 Single-Stranded DNA Proteins 0.000 abstract 1
- 238000002679 ablation Methods 0.000 abstract 1
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 238000003752 polymerase chain reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3519—Fusion with another nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0510612A GB0510612D0 (en) | 2005-05-25 | 2005-05-25 | Polymerase chain reaction |
| GB0510617A GB0510617D0 (en) | 2005-05-25 | 2005-05-25 | Hybrid interfering RNA |
| GB0516191A GB0516191D0 (en) | 2005-08-06 | 2005-08-06 | Polymerase chain reaction |
| GB0516193A GB0516193D0 (en) | 2005-08-06 | 2005-08-06 | Hybrid interfering rna |
| PCT/GB2006/001895 WO2006125977A2 (en) | 2005-05-25 | 2006-05-24 | Hybrid interfering rna |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE546526T1 true ATE546526T1 (de) | 2012-03-15 |
Family
ID=37420934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06743972T ATE546526T1 (de) | 2005-05-25 | 2006-05-24 | Hybrid-interferenz-rna |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US8067572B2 (de) |
| EP (1) | EP1891216B1 (de) |
| AT (1) | ATE546526T1 (de) |
| WO (1) | WO2006125977A2 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1304768B1 (it) * | 1998-10-05 | 2001-03-29 | Esaote Spa | Lettino porta paziente o simili, e macchina, in particolare macchinaper il rilevamento d'immagini in risonanza magnetica nucleare in |
| US8067572B2 (en) * | 2005-05-25 | 2011-11-29 | The University Of York | Hybrid interfering RNA |
| GB0716072D0 (en) * | 2007-08-17 | 2007-09-26 | Univ York | Therapy |
| AU2009279458B2 (en) * | 2008-08-08 | 2015-07-02 | Code Biotherapeutics, Inc. | Long-acting DNA dendrimers and methods thereof |
| KR20110110776A (ko) * | 2008-12-18 | 2011-10-07 | 다이서나 파마수이티컬, 인크. | 유전자 발현의 특이적 억제를 위한 연장된 다이서 기질 제제 및 방법 |
| CN107252489A (zh) | 2009-04-13 | 2017-10-17 | 法国健康和医学研究院 | Hpv颗粒及其用途 |
| WO2011132672A1 (ja) * | 2010-04-19 | 2011-10-27 | 独立行政法人理化学研究所 | 機能性核酸の安定化法 |
| US20110306653A1 (en) | 2010-05-14 | 2011-12-15 | Tagcyx Biotechnologies | Stabilization method of functional nucleic acid |
| EP3269811B1 (de) * | 2010-07-28 | 2020-10-07 | Advanced Innovation Development Co. Ltd. | Nukleinsäure mit adjuvans-aktivität und deren verwendung |
| WO2012016139A2 (en) * | 2010-07-29 | 2012-02-02 | Sirnaomics, Inc. | Sirna compositions and methods for treatment of hpv and other infections |
| CN103328633B (zh) | 2010-10-22 | 2018-07-10 | 成均馆大学校产学协力团 | 诱导rna干扰的核酸分子及其用途 |
| JPWO2013058306A1 (ja) * | 2011-10-19 | 2015-04-02 | 独立行政法人理化学研究所 | 機能性核酸の特異的修飾による活性化 |
| WO2013119877A1 (en) | 2012-02-07 | 2013-08-15 | Aura Biosciences, Inc. | Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells |
| CN108148838B (zh) | 2012-05-22 | 2026-07-31 | 奥利克斯医药有限公司 | 具有细胞内穿透能力的诱导rna干扰的核酸分子及用途 |
| JP6346265B2 (ja) | 2013-03-21 | 2018-06-20 | ジェニスフィア・エルエルシー | Dnaインターカレーティング剤の細胞送達 |
| WO2015042325A1 (en) | 2013-09-18 | 2015-03-26 | Aura Biosciences, Inc. | Virus-like particle conjugates for diagnosis and treatment of tumors |
| KR20180095511A (ko) | 2015-10-30 | 2018-08-27 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 표적화된 암 요법 |
| JP7027311B2 (ja) | 2015-11-16 | 2022-03-01 | オリックス ファーマシューティカルズ,インコーポレーテッド | MyD88又はTLR3を標的とするRNA複合体を使用した加齢黄斑変性の治療 |
| KR102825945B1 (ko) | 2016-02-02 | 2025-06-30 | 올릭스 주식회사 | Angpt2 및 pdgfb를 표적화하는 rna 복합체를 사용하는 혈관신생 관련 질환의 치료 |
| WO2017134525A1 (en) | 2016-02-02 | 2017-08-10 | Olix Pharmaceuticals, Inc. | TREATMENT OF ATOPIC DERMATITIS AND ASTHMA USING RNA COMPLEXES THAT TARGET lL4Rα, TRPA1, OR F2RL1 |
| WO2017143156A1 (en) | 2016-02-19 | 2017-08-24 | Genisphere Llc | Nucleic acid carriers and therapeutic methods of use |
| JP7049262B2 (ja) | 2016-04-11 | 2022-04-06 | オリックス ファーマシューティカルズ,インコーポレーテッド | 結合組織成長因子を標的とするrna複合体を用いた特発性肺胞線維症の治療 |
| KR101916652B1 (ko) | 2016-06-29 | 2018-11-08 | 올릭스 주식회사 | 작은 간섭 rna의 rna 간섭효과 증진용 화합물 및 이의 용도 |
| WO2018146557A2 (en) | 2017-02-10 | 2018-08-16 | Dong Ki Lee | Long double-stranded rna for rna interference |
| AU2018251788B2 (en) | 2017-04-12 | 2025-04-10 | Aura Biosciences, Inc. | Targeted combination therapy |
| JP7535047B2 (ja) * | 2018-12-12 | 2024-08-15 | ディセルナ ファーマシューティカルズ インコーポレイテッド | トリループを含む二本鎖核酸インヒビター分子 |
| CN114072503A (zh) * | 2019-07-02 | 2022-02-18 | 阿尔戈诺特Rna有限公司 | 载脂蛋白b拮抗剂 |
| CN110269014B (zh) * | 2019-07-23 | 2021-01-12 | 中国海洋大学 | 一种单环刺螠幼虫的rna干扰方法 |
| US20230183694A1 (en) * | 2020-03-16 | 2023-06-15 | Argonaute RNA Limited | Antagonist of pcsk9 |
| US20250304966A1 (en) | 2020-12-23 | 2025-10-02 | Argonaute RNA Limited | Treatment of cardiovascular disease |
| GB202020534D0 (en) * | 2020-12-23 | 2021-02-03 | Argonaute Rna Ltd | Conjugate |
| WO2022166849A1 (en) * | 2021-02-08 | 2022-08-11 | Ractigen Therapeutics | Multi-valent oligonucleotide agent and methods of use thereof |
| US20250283076A1 (en) * | 2021-09-14 | 2025-09-11 | Argonaute RNA Limited | Treatment of cardiovascular disease |
| GB2618915B (en) * | 2022-05-18 | 2024-08-14 | Argonaute Rna Ltd | Treatment of cardiovascular disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030206887A1 (en) * | 1992-05-14 | 2003-11-06 | David Morrissey | RNA interference mediated inhibition of hepatitis B virus (HBV) using short interfering nucleic acid (siNA) |
| JP2004535813A (ja) * | 2001-07-17 | 2004-12-02 | ミルナー,アン,ジョセフィーヌ | 遺伝子発現のサイレンシング |
| US20030194718A1 (en) * | 2002-04-15 | 2003-10-16 | Hitachi. Ltd. | Probing sequence determination system for DNA arrays |
| CA2505603A1 (en) * | 2002-11-18 | 2004-06-03 | Genospectra, Inc. | Caged sensors, regulators and compounds and uses thereof |
| JP2004261002A (ja) * | 2003-01-08 | 2004-09-24 | Tsutomu Suzuki | siRNAの製造方法 |
| US7407784B2 (en) * | 2003-01-20 | 2008-08-05 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | L-amino acid oxidase with cytotoxic activity from Aplysia punctata |
| WO2006078798A2 (en) | 2005-01-18 | 2006-07-27 | Sirna Therapeutics, Inc. | RNA INTERFERENCE MEDIATED INHIBITION OF RETINOBLASTOMA (RB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| US8067572B2 (en) * | 2005-05-25 | 2011-11-29 | The University Of York | Hybrid interfering RNA |
-
2006
- 2006-05-24 US US11/915,147 patent/US8067572B2/en not_active Expired - Lifetime
- 2006-05-24 WO PCT/GB2006/001895 patent/WO2006125977A2/en not_active Ceased
- 2006-05-24 EP EP06743972A patent/EP1891216B1/de not_active Expired - Lifetime
- 2006-05-24 AT AT06743972T patent/ATE546526T1/de active
-
2011
- 2011-10-11 US US13/271,052 patent/US20120136040A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006125977A2 (en) | 2006-11-30 |
| EP1891216A2 (de) | 2008-02-27 |
| EP1891216B1 (de) | 2012-02-22 |
| US20090012022A1 (en) | 2009-01-08 |
| US8067572B2 (en) | 2011-11-29 |
| WO2006125977A3 (en) | 2007-01-25 |
| US20120136040A1 (en) | 2012-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006125977A3 (en) | Hybrid interfering rna | |
| BRPI0819193A2 (pt) | uso de oligonucleotídeos com bases modificadas na hibridização de ácidos nucleicos. | |
| MX2008008261A (es) | Intercambio nucleotidico dirigido mejorado con oligonucleotidos modificados por lna. | |
| EP1731525A4 (de) | Nukleotidderivate und dna-mikroarray | |
| DK1713912T3 (da) | Modificerede Korte Interfererende RNA (Modificerede siRNA) | |
| EP2294195A4 (de) | Oligonukleotid-duplexe mit dna-ähnlichen und rna-ähnlichen nukleotiden und verwendungen dafür | |
| EP2089517A4 (de) | Polymeraseenzyme und reagenzien für erweiterte nukeinsäuresequenzierung | |
| EP1723162A4 (de) | Anti-mikrorna-oligonukleotidmoleküle | |
| EP2064223A4 (de) | Duplexoligonukleotide und verfahren zum gen-silencing durch rna-interferenz | |
| EP1646639B8 (de) | Nucleotid-phosphoramidate als antikrebs- verbindungen | |
| PL1807520T3 (pl) | Konstrukty do RNA | |
| ATE542922T1 (de) | 2'-terminator-assoziierte pyrophosphorolyse- aktivierte polymerisierung | |
| ATE502122T1 (de) | Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation | |
| WO2009039189A3 (en) | Compositions comprising stat3 sirna and methods of use thereof | |
| WO2008087641A3 (en) | H19 silencing nucleic acid agents for treating rheumatoid arthritis | |
| WO2005049832A3 (en) | FcϜRIIA-SPECIFIC NUCLEIC ACID INTERFERENCE | |
| WO2008016906A3 (en) | 3'-phosphate-labeled nucleotide analogs and their use for sequencing a nucleic acid | |
| DE602005027253D1 (de) | Herbizidresistenz verleihende gene | |
| WO2007014077A3 (en) | Rnai modulation of the rho-a gene and uses thereof | |
| ATE407939T1 (de) | 2ß-NITROBENZYL-MODIFIZIERTE RIBONUKLEOTIDE | |
| EP2157182A3 (de) | Modifizierte kurz interferierende RNA | |
| IL197415A0 (en) | Azole nucleosides and use as inhibitors of rna and dna varial polymerases | |
| GB0621361D0 (en) | Use of DNA polymerases | |
| WO2007084359A3 (en) | Compositions and methods for the treatment of influenza infection | |
| IL189540A0 (en) | Chemically modified short interfering nucleic acid molecules that mediate rna interference |